PTC Therapeutics | PTCT - Ebit


PTC Therapeutics reported $3.49M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Alnylam Pharmaceuticals USD -29.96M 34.85M Sep/2025
Amgen USD 4.43B 2.17B Sep/2025
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Novartis USD -9.19B 13.87B Jun/2025
Pfizer USD 4.57B 1.97B Sep/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025
Xencor USD -47.52M 24.69M Sep/2025